Maven Securities LTD Buys Shares of 180,543 Guardian Pharmacy Services, Inc. (NYSE:GRDN)

Maven Securities LTD purchased a new position in shares of Guardian Pharmacy Services, Inc. (NYSE:GRDN) in the third quarter, HoldingsChannel reports. The institutional investor purchased 180,543 shares of the company’s stock, valued at approximately $3,033,000.

A number of other institutional investors and hedge funds have also bought and sold shares of the stock. Stephens Inc. AR acquired a new stake in Guardian Pharmacy Services during the third quarter worth about $189,000. Royce & Associates LP bought a new position in Guardian Pharmacy Services in the third quarter worth $1,260,000. Foundry Partners LLC bought a new stake in Guardian Pharmacy Services in the 3rd quarter valued at $1,680,000. Seven Grand Managers LLC acquired a new position in shares of Guardian Pharmacy Services in the 3rd quarter valued at $2,515,000. Finally, Allspring Global Investments Holdings LLC bought a new stake in Guardian Pharmacy Services in the third quarter valued at about $5,460,000.

Wall Street Analyst Weigh In

A number of research firms have weighed in on GRDN. Raymond James started coverage on Guardian Pharmacy Services in a report on Monday, October 21st. They set an “outperform” rating and a $21.00 price objective on the stock. Truist Financial increased their price objective on Guardian Pharmacy Services from $22.00 to $24.00 and gave the stock a “buy” rating in a research note on Friday, November 15th. Finally, Stephens began coverage on shares of Guardian Pharmacy Services in a research note on Tuesday, October 22nd. They issued an “overweight” rating and a $21.00 target price on the stock.

Guardian Pharmacy Services Trading Up 2.8 %

Shares of GRDN stock opened at $24.97 on Wednesday. The business’s fifty day simple moving average is $19.74. Guardian Pharmacy Services, Inc. has a 52 week low of $14.16 and a 52 week high of $25.57.

Guardian Pharmacy Services (NYSE:GRDN) last posted its quarterly earnings data on Tuesday, November 12th. The company reported ($2.00) earnings per share for the quarter, missing the consensus estimate of $0.19 by ($2.19). The business had revenue of $314.39 million for the quarter, compared to analysts’ expectations of $303.21 million. As a group, equities analysts predict that Guardian Pharmacy Services, Inc. will post 0.86 EPS for the current year.

Insider Activity

In related news, Director Thomas J. Salentine, Jr. purchased 35,714 shares of Guardian Pharmacy Services stock in a transaction dated Friday, September 27th. The shares were acquired at an average cost of $14.00 per share, for a total transaction of $499,996.00. Following the transaction, the director now directly owns 35,714 shares of the company’s stock, valued at approximately $499,996. This trade represents a ∞ increase in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this link. Also, Director Steven D. Cosler acquired 7,000 shares of the company’s stock in a transaction that occurred on Tuesday, November 19th. The stock was bought at an average price of $21.22 per share, with a total value of $148,540.00. Following the acquisition, the director now directly owns 17,713 shares of the company’s stock, valued at $375,869.86. The trade was a 65.34 % increase in their position. The disclosure for this purchase can be found here.

Guardian Pharmacy Services Company Profile

Guardian Pharmacy Services, Inc, a pharmacy service company, provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities and behavioral health facilities and group homes.